Author: tmg_admin

Obesity and type 2 diabetes (T2D) represent interconnected metabolic disorders that pose significant global health challenges. Obesity, defined as a body mass index (BMI) of 30 kg/m² or higher, involves excessive adipose tissue accumulation driven by genetic, environmental, and behavioral factors, leading to chronic inflammation and insulin resistance. T2D, characterized by hyperglycemia due to impaired…

Obesity is a chronic, multifactorial medical condition characterized by excess body fat that significantly increases the risk of adverse health outcomes—even in individuals who do not have Type 2 Diabetes (T2DM). While obesity is commonly associated with diabetes, many adults with obesity maintain normal glucose levels yet still experience substantial metabolic, cardiovascular, and mechanical health…

Knee osteoarthritis (OA) is a prevalent degenerative joint disease characterized by the progressive breakdown of articular cartilage, subchondral bone remodeling, and synovial inflammation, leading to pain, stiffness, and reduced mobility. Affecting over 250 million people worldwide, it is a leading cause of disability, particularly among older adults, with significant socioeconomic implications including healthcare costs exceeding…

At Paragon, we are dedicated to advancing medical research and improving patient care through high-quality clinical trials across California. Our mission is simple: to connect individuals with innovative treatments while supporting the development of tomorrow’s medicine. With a focus on precision, diversity, and dedication, Paragon partners with leading physicians, research sponsors, and communities to ensure…